Works matching IS 03065251 AND DT 2024 AND VI 90 AND IP 10
Results: 33
Appropriateness of ChatGPT as a resource for medication‐related questions.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2691, doi. 10.1111/bcp.16212
- By:
- Publication type:
- Article
Optimizing anticoagulation therapy for in‐hospital patients on direct oral anticoagulants: a single‐centre modified Delphi study.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2673, doi. 10.1111/bcp.16159
- By:
- Publication type:
- Article
Nurses' responses to patients' medication self‐management problems in hospital and the use of recommendations.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2684, doi. 10.1111/bcp.16204
- By:
- Publication type:
- Article
Cross‐disciplinary mathematical modelling to benefit healthcare – could clinical pharmacology play an enabling role?
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2509, doi. 10.1111/bcp.16192
- By:
- Publication type:
- Article
Issue Highlights.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2325, doi. 10.1111/bcp.16256
- Publication type:
- Article
Safe and supportive prescribing in transgender and non‐binary patients with cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2401, doi. 10.1111/bcp.16235
- By:
- Publication type:
- Article
Clinical pharmacology in adolescent transgender medicine.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2387, doi. 10.1111/bcp.16213
- By:
- Publication type:
- Article
Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2483, doi. 10.1111/bcp.16181
- By:
- Publication type:
- Article
Protocol of a drug–drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2349, doi. 10.1111/bcp.16162
- By:
- Publication type:
- Article
Effects on cerebral blood flow after single doses of the β<sub>2</sub> agonist, clenbuterol, in healthy volunteers and patients with mild cognitive impairment or Parkinson's disease.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2638, doi. 10.1111/bcp.16160
- By:
- Publication type:
- Article
The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta‐analysis.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2409, doi. 10.1111/bcp.16200
- By:
- Publication type:
- Article
Initiation of lipid‐lowering therapy as primary prevention of cardiovascular disease in the elderly.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2663, doi. 10.1111/bcp.16157
- By:
- Publication type:
- Article
Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2630, doi. 10.1111/bcp.16156
- By:
- Publication type:
- Article
Evaluation of adherence to abiraterone therapy in prostate cancer patients based on a population pharmacokinetic model.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2652, doi. 10.1111/bcp.16155
- By:
- Publication type:
- Article
Low‐dose pegylated recombinant human granulocyte‐colony stimulating factor as hematopoietic support for adjuvant chemotherapy in Chinese patients with breast cancer: An open‐label, randomized, non‐inferiority trial.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2621, doi. 10.1111/bcp.16151
- By:
- Publication type:
- Article
The pharmacokinetic differences between 10‐ and 15‐μg daily vitamin D doses.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2611, doi. 10.1111/bcp.16146
- By:
- Publication type:
- Article
Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram‐negative bacterial infections.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2597, doi. 10.1111/bcp.16145
- By:
- Publication type:
- Article
Impact of modifications to antidementia drug reimbursement in France: Analysis of the FRA‐DEM cohort.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2582, doi. 10.1111/bcp.16143
- By:
- Publication type:
- Article
A potential novel treatment for cirrhosis‐related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2529, doi. 10.1111/bcp.16139
- By:
- Publication type:
- Article
Effects of the phosphodiesterase 2 inhibitor BI 474121 on central nervous system cyclic guanosine monophosphate concentrations: Translational studies.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2517, doi. 10.1111/bcp.16137
- By:
- Publication type:
- Article
Moving forward to 'put people first'.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2326, doi. 10.1111/bcp.16136
- By:
- Publication type:
- Article
Application of immunocapture and nanoflow LC–MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2562, doi. 10.1111/bcp.16135
- By:
- Publication type:
- Article
Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2539, doi. 10.1111/bcp.16134
- By:
- Publication type:
- Article
Belantamab mafodotin concentration–QTc relationships in patients with relapsed or refractory multiple myeloma from the DREAMM‐1 and ‐2 studies.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2571, doi. 10.1111/bcp.16133
- By:
- Publication type:
- Article
Pharmacokinetic study of erlotinib in a pregnant woman with advanced non‐small cell lung cancer and observation of the effects on the child growth.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2554, doi. 10.1111/bcp.16120
- By:
- Publication type:
- Article
Drug–drug interactions between gender‐affirming hormone therapy and antiretrovirals for treatment/prevention of HIV.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2366, doi. 10.1111/bcp.16097
- By:
- Publication type:
- Article
Transgender people in clinical trials of drugs and biologics: An analysis of ClinicalTrials.gov from 2007 to 2023.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2332, doi. 10.1111/bcp.16076
- By:
- Publication type:
- Article
The importance of addressing the research gap in transmasculine individuals: pharmacological and research considerations.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2398, doi. 10.1111/bcp.16086
- By:
- Publication type:
- Article
Incorporating transgender and nonbinary participants in phase 1 clinical drug trials: Current knowledge gaps and considerations.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2343, doi. 10.1111/bcp.16073
- By:
- Publication type:
- Article
No observed bidirectional effect between tenofovir diphosphate concentrations and gender‐affirming hormone concentrations among transgender persons switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre‐exposure prophylaxis
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2360, doi. 10.1111/bcp.16071
- By:
- Publication type:
- Article
A case report highlighting drug–drug interactions between 3 life‐saving treatments: Feminizing hormones, antiretrovirals and antituberculosis drugs.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2383, doi. 10.1111/bcp.16064
- By:
- Publication type:
- Article
Community partnership to optimize engagement in research: Reflections on the trans women HIV research initiative.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2329, doi. 10.1111/bcp.16038
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 10, p. 2323, doi. 10.1111/bcp.15772
- Publication type:
- Article